Texas A&M Law Scholarship
metadata only
Biologics Under a New NAFTA: How TPP Fixed NAFTA's Intellectual Property Provisions But Not Its Investment Provisions
Scientific developments, such as biologics and personalized medicine, have created an entirely new category of pharmaceutical drugs that were not considered when the North American Free Trade Agreement (“NAFTA”) was adopted in 1994. However, the rise of biologics has increased demand for a reconfigu
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) Regulations 2026 (2026)#324043
- The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) (No. 2) Regulations 2026 (2026)#648840
- A long war begins: biosimilars versus patented biologics#168467
- An Analysis of The Biomedical Sectors in Australia and Canada in a National Innovation Systems Context#1026050
- Principles and practices for successful gene therapy innovative contracting: Insights from a multistakeholder convening.#335939
Record · ID 1021897
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive